Effects of human elastase on von Willebrand factor in highly purified factor VIII concentrate and in cryoprecipitate

Thrombosis Research
M JeleńskaK Breddin

Abstract

The susceptibility of v. Willebrand factor (vWF) and F.VIII in virus-inactivated factor VIII/vWF concentrate (Behring-Haemate-HS (BHS] and in cryoprecipitate (Behring-Ristofact) to digestion by highly purified, cathepsin G free human neutrophil elastase (HNE) was compared. In Haemate-HS HNE induced a degradation of the vWF subunit. This reaction was dependent on time and enzyme concentration. It resulted in disappearance of large size vWF multimers, an anodal shift of vWF peak in crossed immunoelectrophoresis and a decrease of F.VIII:C and Ristocetin cofactor activities. In contrast in cryoprecipitate even high HNE concentration did not provoke changes of these parameters. Both Haemate-HS and Ristofact were free of alpha 1-proteinase inhibitor (alpha 1 PI) and alpha 2-macroglobulin (alpha 2 M) but they differed in the content of other contaminating proteins. In particular Haemate-HS was fibrinogen-free but Ristofact contained 6.6 mg/ml. Purified fibrinogen added to Haemate-HS was found highly effective in protecting vWF in Haemate-HS against the proteolytic degradation and loss of activity under the influence of HNE.

Citations

Apr 1, 1996·Journal of Mental Health Administration·M C Masland
Apr 26, 2014·Haemophilia : the Official Journal of the World Federation of Hemophilia·S KitchenK Mertens
Mar 29, 2021·Journal of Thrombosis and Haemostasis : JTH·Alexander St JohnJosé López

❮ Previous
Next ❯

Related Concepts

Related Feeds

Blood Clotting Disorders

Thrombophilia includes conditions with increased tendency for excessive blood clotting. Blood clotting occurs when the body has insufficient amounts of specialized proteins that make blood clot and stop bleeding. Here is the latest research on blood clotting disorders.